BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16817762)

  • 1. Immune response to vaccination against Argentine hemorrhagic Fever in an area where different arenaviruses coexist.
    Ambrosio AM; Riera LM; Saavedra Mdel C; Sabattini MS
    Viral Immunol; 2006; 19(2):196-201. PubMed ID: 16817762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
    Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
    Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclasses in human immune response to wild and attenuated (vaccine) Junin virus infection.
    del Carmen Saavedra M; Sottosanti JM; Riera L; Ambrosio AM
    J Med Virol; 2003 Mar; 69(3):447-50. PubMed ID: 12526057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
    J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.
    Emonet SF; Seregin AV; Yun NE; Poussard AL; Walker AG; de la Torre JC; Paessler S
    J Virol; 2011 Feb; 85(4):1473-83. PubMed ID: 21123388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques.
    McKee KT; Oro JG; Kuehne AI; Spisso JA; Mahlandt BG
    Intervirology; 1992; 34(3):154-63. PubMed ID: 1338783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical assay of candid #1 vaccine against Argentine Hemorrhagic Fever made in Argentina].
    Ambrosio AM; Riera LM; Saavedra Mdel C; Sottosanti MJ
    Medicina (B Aires); 2005; 65(4):329-32. PubMed ID: 16193711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A refined complement-enhanced neutralization test for detecting antibodies to Junin virus.
    Barrera Oro JG; McKee KT; Spisso J; Mahlandt BG; Maiztegui JI
    J Virol Methods; 1990 Jul; 29(1):71-80. PubMed ID: 2170437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subclinical infection, clinical infection and vaccination with Junin virus].
    Weissenbacher M; De Guerrero LB; Frigerio MJ
    Medicina (B Aires); 1976; 36(1):1-8. PubMed ID: 180380
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.
    Clark LE; Mahmutovic S; Raymond DD; Dilanyan T; Koma T; Manning JT; Shankar S; Levis SC; Briggiler AM; Enria DA; Wucherpfennig KW; Paessler S; Abraham J
    Nat Commun; 2018 May; 9(1):1884. PubMed ID: 29760382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argentine hemorrhagic fever vaccines.
    Ambrosio A; Saavedra M; Mariani M; Gamboa G; Maiza A
    Hum Vaccin; 2011 Jun; 7(6):694-700. PubMed ID: 21451263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity.
    Koma T; Huang C; Coscia A; Hallam S; Manning JT; Maruyama J; Walker AG; Miller M; Smith JN; Patterson M; Abraham J; Paessler S
    PLoS Pathog; 2021 Mar; 17(3):e1009356. PubMed ID: 33647064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
    Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
    J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques.
    McKee KT; Oro JG; Kuehne AI; Spisso JA; Mahlandt BG
    Am J Trop Med Hyg; 1993 Mar; 48(3):403-11. PubMed ID: 8385886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description and characterization of a novel live-attenuated tri-segmented Machupo virus in Guinea pigs.
    Zaza AD; Herbreteau CH; Peyrefitte CN
    Virol J; 2018 Jun; 15(1):99. PubMed ID: 29879985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
    López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
    J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety].
    Enria DA; Ambrosio AM; Briggiler AM; Feuillade MR; Crivelli E;
    Medicina (B Aires); 2010; 70(3):215-22. PubMed ID: 20529769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term protection against Argentine hemorrhagic fever in Tacaribe virus infected marmosets: virologic and histopathologic findings.
    Samoilovich SR; Calello MA; Laguens RP; Weissenbacher MC
    J Med Virol; 1988 Feb; 24(2):229-36. PubMed ID: 2832541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypic markers of attenuation in Junin virus strains recently isolated from individuals vaccinated with Junin Candid#1 strain].
    Gamboa GS; Ambrosio AM; Maiza AS; Mariani M; Rodrigues Garcia Armôa G; Saavedra Mdel C
    Medicina (B Aires); 2013; 73(4):303-9. PubMed ID: 23924527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study of protective properties of attenuated strain of Argentinian hemorrhagic fever].
    Ignat'ev GM; Blinov VM; Romanowski V
    Vopr Virusol; 1996; 41(4):158-61. PubMed ID: 8999669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.